|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q56555271
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235757.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q56555271
|
|
024
|
|
|
‡a
0000-0002-5848-404X
‡2
orcid
|
|
024
|
|
|
‡a
6503923753
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q56555271
|
|
100
|
0 |
|
‡a
Josué da Costa Lima-Junior
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Josué da Costa Lima-Junior
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's Alterations in cytokines and haematological parameters during the acute and convalescent phases of Plasmodium falciparum and Plasmodium vivax infections
|
|
670
|
|
|
‡a
Author's Antibody Responses Against Plasmodium vivax TRAP Recombinant and Synthetic Antigens in Naturally Exposed Individuals From the Brazilian Amazon
|
|
670
|
|
|
‡a
Author's Cells and mediators of inflammation (C-reactive protein, nitric oxide, platelets and neutrophils) in the acute and convalescent phases of uncomplicated Plasmodium vivax and Plasmodium falciparum infection.
|
|
670
|
|
|
‡a
Author's Correlation of APRIL with production of inflammatory cytokines during acute malaria in the Brazilian Amazon.
|
|
670
|
|
|
‡a
Author's Corrigendum: Virulence Factor A2 Protein: Linear B-Cell Epitope Mapping and Identification of Three Main Linear B-Cell Epitopes in Vaccinated and Naturally Infected Dogs
|
|
670
|
|
|
‡a
Author's Evaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*/DQB1* in malaria exposed individuals from the Brazilian Amazon.
|
|
670
|
|
|
‡a
Author's How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?
|
|
670
|
|
|
‡a
Author's IL10A genotypic association with decreased IL-10 circulating levels in malaria infected individuals from endemic area of the Brazilian Amazon
|
|
670
|
|
|
‡a
Author's Immunogenicity of synthetic peptide constructs based on PvMSP9E795-A808, a linear B-cell epitope of the P. vivax Merozoite Surface Protein-9
|
|
670
|
|
|
‡a
Author's In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9
|
|
670
|
|
|
‡a
Author's Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera
|
|
670
|
|
|
‡a
Author's Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area.
|
|
670
|
|
|
‡a
Author's Intestinal parasites coinfection does not alter plasma cytokines profile elicited in acute malaria in subjects from endemic area of Brazil.
|
|
670
|
|
|
‡a
Author's Killer cell immunoglobulin-like receptor (KIR) gene diversity in a population naturally exposed to malaria in Porto Velho, Northern Brazil.
|
|
670
|
|
|
‡a
Author's Leishmania infantum Virulence Factor A2 Protein: Linear B-Cell Epitope Mapping and Identification of Three Main Linear B-Cell Epitopes in Vaccinated and Naturally Infected Dogs.
|
|
670
|
|
|
‡a
Author's Major Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection
|
|
670
|
|
|
‡a
Author's Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals
|
|
670
|
|
|
‡a
Author's Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants.
|
|
670
|
|
|
‡a
Author's Plasmodium vivax ookinete surface protein (Pvs25) is highly conserved among field isolates from five different regions of the Brazilian Amazon
|
|
670
|
|
|
‡a
Author's Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon.
|
|
670
|
|
|
‡a
Author's Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon
|
|
670
|
|
|
‡a
Author's Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area
|
|
670
|
|
|
‡a
Author's The influence of intestinal parasites on Plasmodium vivax-specific antibody responses to MSP-119 and AMA-1 in rural populations of the Brazilian Amazon
|
|
909
|
|
|
‡a
(scopus) 6503923753
‡9
1
|
|
909
|
|
|
‡a
(orcid) 000000025848404x
‡9
1
|
|
919
|
|
|
‡a
plasmodiumvivaxookinetesurfaceproteinpvs25ishighlyconservedamongfieldisolatesfrom5differentregionsofthebrazilianamazon
‡A
Plasmodium vivax ookinete surface protein (Pvs25) is highly conserved among field isolates from five different regions of the Brazilian Amazon
‡9
1
|
|
919
|
|
|
‡a
plasmodiumvivaxcelltraversalproteinforookinetesandsporozoitesnaturallyacquiredhumoralimmuneresponseandbcellepitopemappinginbrazilianamazoninhabitants
‡A
Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants.
‡9
1
|
|
919
|
|
|
‡a
naturallyacquiredhumoralandcellularimmuneresponsestoplasmodiumvivaxmerozoitesurfaceprotein9innorthwesternamazonindividuals
‡A
Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals
‡9
1
|
|
919
|
|
|
‡a
majorhistocompatibilitycomplexandmalariafocusonplasmodiumvivaxinfection
‡A
Major Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection
‡9
1
|
|
919
|
|
|
‡a
leishmaniainfantumvirulencefactora2proteinlinearbcellepitopemappingandidentificationof3mainlinearbcellepitopesinvaccinatedandnaturallyinfecteddogs
‡A
Leishmania infantum Virulence Factor A2 Protein: Linear B-Cell Epitope Mapping and Identification of Three Main Linear B-Cell Epitopes in Vaccinated and Naturally Infected Dogs.
‡9
1
|
|
919
|
|
|
‡a
killercellimmunoglobulinlikereceptorkirgenediversityinapopulationnaturallyexposedtomalariainportovelhonorthernbrazil
‡A
Killer cell immunoglobulin-like receptor (KIR) gene diversity in a population naturally exposed to malaria in Porto Velho, Northern Brazil.
‡9
1
|
|
919
|
|
|
‡a
intestinalparasitescoinfectiondoesnotalterplasmacytokinesprofileelicitedinacutemalariainsubjectsfromendemicareaofbrazil
‡A
Intestinal parasites coinfection does not alter plasma cytokines profile elicited in acute malaria in subjects from endemic area of Brazil.
‡9
1
|
|
919
|
|
|
‡a
influenceofhladrb1andhladqb1allelesoniggantibodyresponsetothepvivaxmsp1msp3αandmsp9inindividualsfrombrazilianendemicarea
‡A
Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area.
‡9
1
|
|
919
|
|
|
‡a
inductionofmultifunctionalbroadlyreactivetcellresponsesbyaplasmodiumvivaxcircumsporozoiteproteinrecombinantchimera
‡A
Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera
‡9
1
|
|
919
|
|
|
‡a
insilicoidentificationandvalidationofalinearandnaturallyimmunogenicbcellepitopeoftheplasmodiumvivaxmalariavaccinecandidatemerozoitesurfaceprotein9
‡A
In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9
‡9
1
|
|
919
|
|
|
‡a
immunogenicityofsyntheticpeptideconstructsbasedonpvmsp9e795a808alinearbcellepitopeofthepvivaxmerozoitesurfaceprotein9
‡A
Immunogenicity of synthetic peptide constructs based on PvMSP9E795-A808, a linear B-cell epitope of the P. vivax Merozoite Surface Protein-9
‡9
1
|
|
919
|
|
|
‡a
il10agenotypicassociationwithdecreasedil10circulatinglevelsinmalariainfectedindividualsfromendemicareaofthebrazilianamazon
‡A
IL10A genotypic association with decreased IL-10 circulating levels in malaria infected individuals from endemic area of the Brazilian Amazon
‡9
1
|
|
919
|
|
|
‡a
howcanelispotaddinformationtoimproveknowledgeontropicaldiseases
‡A
How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?
‡9
1
|
|
919
|
|
|
‡a
evaluationofnaturallyacquirediggantibodiestoachimericandnonchimericrecombinantspeciesofplasmodiumvivaxreticulocytebindingprotein1lackofassociationwithhladrb1dqb1inmalariaexposedindividualsfromthebrazilianamazon
‡A
Evaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*/DQB1* in malaria exposed individuals from the Brazilian Amazon.
‡9
1
|
|
919
|
|
|
‡a
corrigendumvirulencefactora2proteinlinearbcellepitopemappingandidentificationof3mainlinearbcellepitopesinvaccinatedandnaturallyinfecteddogs
‡A
Corrigendum: Virulence Factor A2 Protein: Linear B-Cell Epitope Mapping and Identification of Three Main Linear B-Cell Epitopes in Vaccinated and Naturally Infected Dogs
‡9
1
|
|
919
|
|
|
‡a
correlationofaprilwithproductionofinflammatorycytokinesduringacutemalariainthebrazilianamazon
‡A
Correlation of APRIL with production of inflammatory cytokines during acute malaria in the Brazilian Amazon.
‡9
1
|
|
919
|
|
|
‡a
cellsandmediatorsofinflammation100reactiveproteinnitricoxideplateletsandneutrophilsintheacuteandconvalescentphasesofuncomplicatedplasmodiumvivaxandplasmodiumfalciparuminfection
‡A
Cells and mediators of inflammation (C-reactive protein, nitric oxide, platelets and neutrophils) in the acute and convalescent phases of uncomplicated Plasmodium vivax and Plasmodium falciparum infection.
‡9
1
|
|
919
|
|
|
‡a
antibodyresponsesagainstplasmodiumvivaxtraprecombinantandsyntheticantigensinnaturallyexposedindividualsfromthebrazilianamazon
‡A
Antibody Responses Against Plasmodium vivax TRAP Recombinant and Synthetic Antigens in Naturally Exposed Individuals From the Brazilian Amazon
‡9
1
|
|
919
|
|
|
‡a
alterationsincytokinesandhaematologicalparametersduringtheacuteandconvalescentphasesofplasmodiumfalciparumandplasmodiumvivaxinfections
‡A
Alterations in cytokines and haematological parameters during the acute and convalescent phases of Plasmodium falciparum and Plasmodium vivax infections
‡9
1
|
|
919
|
|
|
‡a
influenceofintestinalparasitesonplasmodiumvivaxspecificantibodyresponsestomsp119andama1inruralpopulationsofthebrazilianamazon
‡A
The influence of intestinal parasites on Plasmodium vivax-specific antibody responses to MSP-119 and AMA-1 in rural populations of the Brazilian Amazon
‡9
1
|
|
919
|
|
|
‡a
syntheticantigensderivedfromplasmodiumfalciparumsporozoiteliverandbloodstagesnaturallyacquiredimmuneresponseandhumanleukocyteantigenassociationsinindividualslivinginabrazilianendemicarea
‡A
Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area
‡9
1
|
|
919
|
|
|
‡a
recombinantplasmodiumvivaxcircumsporozoitesurfaceproteinallelicvariantsantibodyrecognitionbyindividualsfrom3communitiesinthebrazilianamazon
‡A
Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon
‡9
1
|
|
919
|
|
|
‡a
promiscuoustcellepitopesofplasmodiummerozoitesurfaceprotein9pvmsp9inducesifngammaandil4responsesinindividualsnaturallyexposedtomalariainthebrazilianamazon
‡A
Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon.
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000068310727
|
|
996
|
|
|
‡2
PTBNP|430282
|
|
996
|
|
|
‡2
ISNI|0000000496542057
|
|
996
|
|
|
‡2
BLBNB|001277434
|
|
996
|
|
|
‡2
PTBNP|184702
|
|
996
|
|
|
‡2
PTBNP|43405
|
|
996
|
|
|
‡2
LC|no 98047743
|
|
996
|
|
|
‡2
ISNI|0000000069921423
|
|
996
|
|
|
‡2
ISNI|0000000070718684
|
|
996
|
|
|
‡2
BLBNB|000590668
|
|
996
|
|
|
‡2
PTBNP|120240
|
|
996
|
|
|
‡2
PTBNP|155955
|
|
996
|
|
|
‡2
SUDOC|129679313
|
|
996
|
|
|
‡2
SUDOC|151538883
|
|
996
|
|
|
‡2
PTBNP|1206052
|
|
996
|
|
|
‡2
BLBNB|001133156
|
|
996
|
|
|
‡2
PTBNP|1392979
|
|
996
|
|
|
‡2
ISNI|0000000067230258
|
|
996
|
|
|
‡2
LC|no2017093143
|
|
996
|
|
|
‡2
PTBNP|144481
|
|
996
|
|
|
‡2
ISNI|0000000046454068
|
|
996
|
|
|
‡2
PTBNP|1528896
|
|
996
|
|
|
‡2
PTBNP|241787
|
|
996
|
|
|
‡2
BLBNB|000402020
|
|
996
|
|
|
‡2
ISNI|0000000070606375
|
|
996
|
|
|
‡2
ISNI|0000000073256470
|
|
996
|
|
|
‡2
ISNI|0000000107866235
|
|
996
|
|
|
‡2
PTBNP|152968
|
|
996
|
|
|
‡2
LC|n 2019250883
|
|
996
|
|
|
‡2
ISNI|0000000066819407
|
|
996
|
|
|
‡2
PTBNP|254782
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
